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1. Introduction
The essential role in placentation belongs to trophoblast 
cells, which arise from the outer layer of blastocysts 
(Pennisi et al., 2012). The cytotrophoblast stem cells 
undergo either the villous or the extravillous pathway of 
differentiation. In the villous pathway, cytotrophoblasts 
fuse to form multinucleated syncytiotrophoblasts 
or aggregate to form anchoring villous trophoblasts, 
which give rise to extravillous trophoblasts (Loke et al., 
1995). Villous trophoblasts cover the chorionic villi, 
creating the placental–blood barrier, involved in gas 
exchange and nutrient supply between the mother and 
the fetus. Extravillous trophoblasts deeply invade the 
uterine connective tissue, degrading the extracellular 
matrix (interstitial route), and place themselves between 
decidual and myometrial cells and then invade the uterine 
spiral arteries (endovascular route) (Loke et al., 1995). 
At this stage the extravillous trophoblasts remodel the 
maternal spiral arteries, replacing smooth muscle and 
endothelial cells forming vessels with a larger diameter, 
and increase blood flow and reduce vascular resistance, 
making these maternal vessels independent of maternal 
vasoconstriction. This remodeling invasion is essential 
in establishing and developing the placenta as well as in 
maintaining normal pregnancy, considering that the fetal 
requirement for blood supply is much higher in the later 
stages of pregnancy (Zhou et al., 1997). Since the process 
strongly depends on an optimal trophoblast invasion of 
the maternal tissue environment, failure of extravillous 
trophoblasts to fully invade and modify the uterine tissue 
leads to shallow placentation and is often associated with 
serious pregnancy complications such as preeclampsia and 
intrauterine growth restriction (Chaddha et al., 2004).
Neuropeptide Y (NPY) is a neuropeptide present in 
significant levels in the peripheral and central nervous 
systems and it has a role in various processes such as 
anxiety, stress-related behaviors, food intake, digestion, 
metabolism, immune response, memory, and learning 
(Heilig, 2004; Ferreira et al., 2010; Farzi et al., 2015). 
Literature data show that levels of NPY in patients with 
preeclampsia and eclampsia, both caused by inadequate 
placentation, are 2- to 4-fold higher than in women with 
normal pregnancies (Khatun et al., 2000). 
The production of reactive oxygen species is a 
physiological process inherent to aerobic organisms due 
to mitochondrial respiratory chain activity and phagocytic 
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actions (Nazıroğlu et al., 2015). Oxidative stress represents 
an imbalance between the production of reactive oxygen 
species and the compensating antioxidant mechanisms, 
which can lead to multiple cellular damages (Li et al., 
2013). 
Nitric oxide (NO) is a multifunctional signal molecule 
and has been reported as a mediator of many physiological 
and pathological processes in a variety of tissues, including 
those involved in human reproduction. NO is one of the 
most pleiotropic signaling molecules at systemic and 
cellular levels, participating in vascular tone regulation, 
cellular respiration, proliferation, apoptosis, and gene 
expression (Krause et al., 2011). Nitric oxide is generated 
from L-arginine by the enzyme nitric oxide synthase 
(NOS). Two of the three known isoforms of NOS are 
constitutively expressed in different cell types (NOS1 or 
neuronal; NOS3 or endothelial NOS - eNOS), whereas 
the expression of the third isoform (NOS2 or inducible 
NOS - iNOS) can be induced with cytokines and other 
agents (Moncada et al., 1991). Both iNOS and eNOS are 
present in human trophoblasts (Rossmanith et al., 1999; 
Hambartsoumian et al., 2001). The quantification of NO 
metabolites (like nitrites and nitrates) in biological samples 
provides valuable information with regard to in vivo NO 
production, bioavailability, and metabolism (Bryan et al., 
2007). The production of NO by iNOS in the myometrium 
and placenta increases throughout pregnancy until 
delivery, when it decreases rapidly (Von Mandach et 
al., 2003). One of the main roles of NO increase during 
pregnancy is to stimulate vasodilatation and to increase 
blood flow subsequently (Benest et al., 2008). Nitric oxide 
activates protein kinase G (PKG), which phosphorylates 
multiple protein substrates including integrins and cell 
adhesion molecules. NO-dependent phosphorylation 
induces conformational changes of the integrins, altering 
their ligand-binding affinity, which affects cell motility 
(Cartwright and Balarajah, 2005; Chigaev et al., 2011).
It was shown in mice and rats that the stimulation 
of macrophages with NPY increased the production of 
reactive oxygen species such as peroxide and superoxide 
(De la Fuente et al., 2001; Dimitrijevic et al., 2005) and that 
these effects are mediated via Y1 and Y2 receptors (Bedoui 
et al., 2008). By stimulating the generation of these reactive 
oxygen molecules, which can alter levels of free NO (Jaimes 
et al., 2001; Hsieh et al., 2014), NPY could be an important 
factor in depletion of cell migration dependent on NO-
mediated pathways. In this study we investigated the 
modulatory capacity of NPY on the mobility of a human 
choriocarcinoma cytotrophoblastic cell line by examining 
its effects on the oxidative/antioxidative balance and 
bioavailability of NO. 
2. Materials and methods
2.1. Cell culture and treatment 
The cytotrophoblastic human choriocarcinoma cell line 
JEG-3, purchased from the American Type Culture 
Collection, was used in this study. The cells were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM, GIBCO) 
supplemented with heat-inactivated 10% fetal bovine 
serum (FBS), penicillin, and streptomycin (GIBCO). The 
cells were grown to 80% confluence in 75-cm2 flasks at 
37 °C in a normal atmosphere containing 5% CO2. This 
cell line is easy to culture and represents a convenient 
model for cell migration. NPY concentrations of 1 nM, 10 
nM, and 100 nM were tested for cytotoxicity. In order to 
investigate the effects of NPY on oxidative/antioxidative 
status and cell migration capacity, 1 nM NPY was used 
as treatment. The stock solution of NPY was prepared in 
phosphate-buffered saline (PBS) and then the NPY stock 
was serially diluted in DMEM to final concentrations of 1 
nM, 10 nM, and 100 nM. The control cells were cultured 
in conditioned medium only (DMEM) to acquire the basal 
levels of oxidative stress parameters and migration index. 
2.2. MTT assay
The cells were seeded into a 96-well plate (10,000 cells per 
well) and incubated at 37 °C and 5% CO2 for 24 h. The 
medium was replaced with 100 µL of medium containing 
various concentrations of NPY (1 nM, 10 nM, and 100 
nM) and cells were incubated for 24 h. Untreated cells were 
used as the control. After 24 h of NPY treatment, the cell 
viability was determined by MTT assay (Mosmann, 1983). 
The test was based on the color reaction of mitochondrial 
dehydrogenase in living cells by MTT. At the end of the 
treatment period, MTT (final concentration: 5 mg/mL 
of phosphate buffer solution) was added to each well, 
which were then incubated at 37 °C in 5% CO2 for 3 h. 
The colored crystals of produced formazan were dissolved 
in 150 µL of DMSO. The absorbance was measured by a 
microplate reader. The cell viability was calculated as a 
ratio of absorbance of the treated group divided by the 
absorbance of the control group and multiplied by 100 to 
give a percentage of viability. 
2.3. Transwell assay for cell migration
The cell migration capacity was determined by the ability 
of cells to cross the pores of polycarbonate membranes 
(pore size 8 µm; Greiner Bio-One, Switzerland) fitted to 
the bottom of transwell chambers. The migration test was 
based on a protocol described by Chen (2005). The cells 
were exposed to 1 nM NPY for 24 h and 72 h, respectively. 
In another set of experiments the cells were incubated 
with 1 mM NG-nitro-L-arginine methyl ester (L-NAME) 
for 24 h and 72 h. The initial solution of L-NAME in 
PBS was used for the study and then the solution was 
diluted in conditioned medium (DMEM) to acquire the 
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1 mM concentration. The control cells were cultured 
only in conditioned medium (DMEM, GIBCO). Each 
measurement was performed in triplicate (3 wells for each 
experimental cell group). After the exposures, all three 
groups of cells were trypsinized and placed in the upper 
chambers at a density of 1 × 105 cells/well in 500 µL of 
DMEM with 10% FBS. The lower chambers of the control 
cells contained 750 µL of DMEM supplemented with 10% 
FBS whereas the lower chambers with treated cells were 
filled with 1 nM NPY or 1 mM L-NAME diluted in 750 
µL of DMEM supplemented with 10% FBS. After 6 h of 
incubation at 37 °C, the cells from the upper surface of 
the filter were completely removed with gentle swabbing. 
The remaining migrated cells were fixed for 20 min at 
room temperature in 4% paraformaldehyde and stained 
with 0.1% crystal violet in 200 mM 2-(N-morpholino)
ethanesulfonic acid (pH 6.0) for 10 min. After adding 
10% acetic acid, absorbance was measured by an ELISA 
microplate reader. The migration index was calculated as 
the ratio of absorbance of the treated group divided by the 
absorbance of the control and multiplied by 100 to give the 
percentage.
2.4. Cell extraction 
After 24 h or 72 h of NPY treatment, cells were trypsinized, 
transferred from each flask into a separate test tube, and 
centrifuged for 10 min at 1000 × g and 4 °C in order to 
remove the culture medium (discarded supernatant). 
The cells were washed with ice-cold PBS (GIBCO), and 
after recentrifugation (10 min, 1000 × g, 4 °C) they were 
resuspended in a volume of PBS in which the number of 
cells was 106/mL. This cell suspension was used for further 
analysis.
2.5. The determination of superoxide anion (O2•–)
NPY-treated cells adjusted to 1 × 106 cells/mL in PBS were 
plated at 100 µL/well in a 96-well flat-bottomed plate and 
mixed with 100 µL of 0.1% nitro blue tetrazolium (NBT). 
The determination of superoxide anion (O2•–) was based 
on the reduction of NBT in the presence of O2•– (Auclair 
and Voisin, 1985). The concentration was expressed as 
nmol/L in 106 cells/mL. 
2.6. NO2− and H2O2 determination 
To determine the concentration of NO2− and H2O2, 
cell membranes were broken by sonication of the cell 
suspension on ice with a series of 10 successive acoustic 
shocks. The samples were then centrifuged for 20 min at 
10,000 × g and 4 °C. The concentrations of nitrites and 
hydrogen peroxide were determined in the supernatant. 
The determinations of nitrites (NO2−, indicator of NO 
concentration) were performed using the Griess method 
(Green et al., 1982). The determination of the hydrogen 
peroxide (H2O2) concentration was based on oxidation of 
phenol red in the presence of horseradish peroxidase as 
a catalyst (Pick and Keisari, 1980). The concentrations of 
both parameters were determined by ELISA microplate 
reader. The concentrations of NO2− were expressed as 
µmol/L in 106 cells, while the levels of H2O2 were expressed 
as nmol/L in 106 cells/mL.
2.7. Glutathione determination
For measuring the concentrations of reduced glutathione 
(GSH) and oxidized glutathione (GSSG), the used 
supernatant was obtained by the following procedure: 
the cell suspension was centrifuged for 10 min at 1000 
× g and 4 °C, and after the removal of supernatant, the 
pellet was resuspended in 2.25% sulfosalicylic acid. Cell 
membranes were lysed by alternate freezing (‒80 °C) 
and thawing (37 °C) in 3 cycles for 15 min followed by 
30 min of centrifugation at 1000 × g. The concentration 
of GSH was determined based on GSH oxidation with 
5.5-dithiobis-6.2-nitrobenzoic acid (Beutler, 1975). The 
concentration of GSSG was determined based on GSH 
determination assay using glutathione reductase (Beutler, 
1975) after inhibition of spontaneous GSH oxidation by 
4-vinylpyridine. Glutathione concentration was expressed 
as µmol/L in 106 cells/mL.
2.8. Statistical analysis
All groups of data were analyzed with SPSS 13.0 for 
Windows. The results are presented as the mean ± SEM 
using the independent t-test to evaluate significant 
differences between experimental groups versus the 
control group. Probability values of less than 0.05 were 
considered significant. 
3. Results
3.1. MTT viability assay
For the assessment of the appropriate concentration of NPY 
to be used for the treatment, the effect of this peptide on 
cytotrophoblast cell viability was examined. To investigate 
the acute effects of NPY on oxidative stress parameters and 
migration capacity, the highest noncytotoxic concentration 
of NPY was used in our study. The results of the MTT 
test showed that only the concentration of 1 nM was not 
cytotoxic for the JEG-3 cell line (more than 95% of cells 
survived). The higher tested concentrations of NPY (10 
nM and 100 nM) significantly caused the decrease of the 
number of living cells (Figure 1). 
3.2. Concentrations of oxidative/antioxidative status 
parameters (O2•−, H2O2, and NO2−)
The concentrations of oxidative stress parameters after 
exposure to 1 nM NPY were measured in our experiment. 
The results showed that the concentrations of O2•– and H2O2 
were significantly increased in cells treated with NPY for 
both 24 h and 72 h compared to the control cells (P < 0.05) 
(Figure 2). In this study the concentrations of NO2− (the 
indicator of NO) after 1 nM NPY treatment of trophoblast 
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cells were also examined. The results showed that NPY 
induced significant decrease in the concentrations of NO2− 
in the cells treated with NPY for 24 h and even stronger 
decrease in long-term (72 h) treatment as compared to 
control cells (P < 0.05) (Figure 2). 
3.4. Concentrations of antioxidant defense system 
parameters (GSH and GSSG) 
The concentrations of GSH in cells treated with NPY both 
for 24 h and 72 h were significantly increased compared 
to control cells (P < 0.05) (Figure 3). Glutathione is one of 
the strongest antioxidative components and its increased 
concentration may indicate de novo synthesis induced 
by NPY. No significant changes in the concentration of 
GSSG were recorded in the cells treated with NPY for 24 
h compared to the control cells (Figure 3), which could 
indicate the initial high activity of glutathione reductase 
(GR) as one of the major enzymes of the antioxidant 
defense system in trophoblasts. However, the GSSG level 
in cells treated with NPY for 72 h was significantly elevated 
compared to control cells (Figure 3).
3.5. Transwell migration assay (Boyden chamber assay)
To examine the effects of NPY on the migration capacity 
of a human trophoblast cell line, a transwell migration 
assay was performed. Results showed 1.38-fold and 1.58-
fold decrease in the cell migration index of JEG-3 cells 
exposed to NPY for 24 h and 72 h, respectively, compared 
to the control cells. Long-term exposure to NPY induced 
Figure 1. The results of MTT viability assay of human 
choriocarcinoma cell line JEG-3 exposed to various concentrations of 
NPY. Data are representative of three independent experiments and 
values are expressed as  mean  ± SEM. *: Statistically significant 
compared to the control group (P < 0.05).
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stronger reduction of trophoblast migration compared to 
24 h of treatment. These data indicate that treatment with 
1 nM NPY significantly reduced the migratory capacity 
of human choriocarcinoma trophoblast cells (Figure 4). 
We proposed that NPY-induced reduction of migration 
capacity was related to a decrease in NO concentration 
during NPY treatment, so we exposed cells to 1 mM 
L-NAME (NOS inhibitor) for 24 h and 72 h. Our results 
showed 2.36-fold decrease in cell migration index in cells 
treated with L-NAME for 24 h and 2.14-fold decrease in 
cells treated with L-NAME for 72 h as compared to control 
cells (Figure 5). By comparing the migration index of the 
cells between NPY treatment and L-NAME treatment we 
could conclude that there was 1.76-fold decrease in cell 
migration index between short-term NPY and L-NAME 
exposures (24 h) (Figure 6a) and 1.36-fold decrease in cell 
migration index between long-term NPY and L-NAME 
exposures (72 h) (Figure 6b). These data indicate that 
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NO depletion by L-NAME, and to a lesser extent by 
NPY, is responsible for decreased cell migration capacity. 
Together, these results suggest that reduced migration of 
human trophoblast cell line JEG-3 could be mediated by 
decreased levels of NO.
4. Discussion
Trophoblast migration is an essential step in successful 
implantation and formation of the placenta (Pijnenborg 
et al., 1983; Knöfler and Pollheimer, 2013). Khatun et 
al. (2000) showed that high concentrations of NPY may 
contribute to the development of preeclampsia, which 
is characterized by shallow trophoblast invasion. We 
proposed that NPY, regarding its increased level in 
preeclampsia, could be one of the factors that affect the 
migratory capacity of trophoblast cells by inducing 
oxidative stress. Various studies reported signal pathways 
that can affect the oxidative/antioxidative balance in cells. 
NPY has been shown to trigger the phospholipase C-protein 
kinase C (PLC-PKC) pathway, activating nicotinamide 
adenine dinucleotide phosphate oxidase (NADPH 
oxidase) via its receptors in human syncytiotrophoblasts 
and hamster suprachiasmatic nuclei cells (Robidoux et al., 
1998; Schak et al., 2001). NADPH oxidase is an important 
respiratory chain enzyme and represents the main source 
of superoxide anion radical (O2•–) in neutrophils, vascular 
endothelial cells, smooth muscle cells, and trophoblasts 
(Griendling et al., 2000; Halliwell and Gutteridge, 2007). 
So far, the Y1 and Y3 receptors for this peptide have been 
described in human trophoblasts as a mixed population 
(Robidoux et al., 1998, 2000). Prooxidative effects of 
neuropeptide Y mediated via Y1 and Y2 receptors were 
recorded in macrophages (Dimitrijevic et al., 2005; Bedoui 
et al., 2008), suggesting that elevated levels of reactive 
oxygen species in trophoblasts exposed to NPY could be 
caused by the elevated activity of NADPH oxidase in these 
cells. However, the possible activity alterations of NADPH 
oxidase induced by NPY exposure in trophoblasts are yet 
to be determined.
In this study we measured both the levels of reduced 
glutathione (GSH) and oxidized glutathione (GSSG). 
Although these molecules might not directly interfere 
with nitric oxide, they are accepted as important 
markers of the oxidative/antioxidative status of the cell. 
Glutathione levels were measured in order to elucidate 
the intensity of oxidative stress induced by neuropeptide 
Y in trophoblasts, and to examine some antioxidative 
performances of these cells as well. The results showed 
increased levels of glutathione in both NPY treatments 
(24 h and 72 h). Reduced glutathione, a tripeptide 
consisting of cysteine, glutamate, and glycine, is one of the 
strongest antioxidative components in cells, maintaining 
intracellular thiol status and detoxicating various 
metabolites, essential for optimal activity of some enzymes 
and other cellular macromolecules (Chung et al., 2016). 
Since GSH is a potent electron donor, it represents the 
major nonenzymatic antioxidant component and one of 
the most important scavengers of free radicals, converting 
itself to the oxidized dimeric form, GSSG (Jones, 2002). 
Increased concentrations of reduced glutathione (GSH) 
recorded in our experiment suggest de novo synthesis 
of GSH induced by NPY. GSH is synthesized in cells de 
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novo and rapid induction of intracellular GSH synthesis 
occurs in response to various stressors (Kondo et al., 
1993; Shi et al., 1994). Oxidative stress has been shown 
to induce transcriptional upregulation of the enzyme in 
the GSH biosynthesis pathway, γ GCS-gamma-glutamyl-
cysteine synthetase (Rahman and MacNee, 1999; Ray et 
al., 2002). The cell culture medium (DMEM) contains 
a significant amount of cystine, which is one of the 
components used in GSH biosynthesis. Our results show 
the elevated levels of glutathione (GSH), which might 
be caused by de novo synthesis. The increased activity 
of GSH biosynthesis enzymes could be due to the high 
concentrations of reactive oxygen species generated in 
trophoblasts by NPY. Elevated GSH levels appear to be an 
important defense mechanism in human cytotrophoblasts 
in response to aggressive oxidative stress radicals induced 
by NPY. An increase in GSSG levels and reduction of 
the GSH/GSSG ratio indicates glutathione antioxidative 
activity in response to oxidative stress, which could lead to 
numerous cell damages (Lu, 2009). No significant changes 
in the concentrations of GSSG were recorded in cells 
treated with NPY for 24 h compared to the control cells 
(Figure 3), which could indicate the initial high activity of 
glutathione reductase (GR) as one of the major enzymes 
of the antioxidant defense system in trophoblasts. Since 
trophoblasts have stem cell features, the basal antioxidative 
activity of these cells may be higher compared to the other 
highly differentiated cell types (Aplin et al., 1999; Baczyk et 
al., 2006; Shenghui et al., 2009; Kobayashi and Suda, 2012). 
However, after long-term NPY exposure, trophoblast cells 
express increased levels of oxidized glutathione (GSSG). 
This elevation might be caused by prolonged production 
of reactive oxygen species generated by long-term NPY 
exposure, exceeding the reductive capacity of the GR 
enzyme and leading to accumulation of GSSG. The activity 
of GR and other antioxidant defense enzymes in JEG-3 
cells is yet to be determined. Our results indicate the high 
basic antioxidant potential of trophoblasts, which could 
mean that NPY has the ability to generate an abundant 
burst of reactive oxygen species in trophoblast cells. The 
increased levels of H2O2 and O2•– during NPY exposure 
demonstrated in our study suggest that this peptide is a 
significant inducer of oxidative stress in this cell line.
In human trophoblasts both iNOS and eNOS are 
present, so these cells synthesize NO (Rossmanith et al., 
1999; Hambartsoumian et al., 2001). Various actions of 
nitric oxide are known to contribute to the maintenance 
of pregnancy. Numerous data show that oxidative stress 
contributes to altered NO bioavailability (Pandey and Rizvi, 
2010; Prokić et al., 2015). Superoxide anion radical, when 
produced in high concentrations, scavenges nitric oxide 
and forms cytotoxic peroxynitrite (ONOO−) (Jourd’heuil 
et al., 2001; Calabrese et al., 2007). Not only does the 
superoxide anion radical oxidize lipids and proteins in 
cell membranes and cytoplasm, but the formation of 
peroxynitrites also results in reduced NO bioavailability, 
affecting NO-mediated pathways. Nitric oxide has been 
shown to affect cell migration and invasion in a variety 
of cell types (Murohara et al., 1999; Giordano et al., 2006; 
Li et al., 2009). In vitro studies showed that motility and 
invasion of trophoblast cells also depend on trophoblast-
derived NOS (Cartwright et al., 1999; Harris et al., 2008). 
Nitric oxide has significant roles in cell migration via 
regulation of integrin phosphorylation (Chigaev et al., 
2011). NO appears to be involved in the regulation of the 
phosphorylated state of two adhesion molecules, VCAM-
1 (vascular cell adhesion molecule-1) and α4β1 integrin. 
These adhesion molecules are important in trophoblast 
interaction with endothelial cells in uterine arteries and 
their ligand binding affinity depends on phosphorylation 
performed by NO-dependent protein kinase G 
(Cartwright and Balarajah, 2005). In this study, the effects 
of NO depletion in the JEG-3 cell line on cell migration 
capacity were examined by treating the cells with 1 mM 
L-NAME, which is the inhibitor of NOS enzymes. Our 
data showed over 2-fold decrease in migration capacity 
(Figure 5), suggesting the essential role of nitric oxide 
in the migration mechanisms of these cells. The results 
obtained in a study by Harris et al. suggest that nitric oxide 
could also promote trophoblast invasion by mechanisms 
other than phosphorylation; S-nitrosylation of proteins at 
the leading edge of trophoblasts contributes to the elevated 
migration of these cells (Harris et al., 2008). The results of 
our experiment show that NPY treatment increased O2•– 
and decreased NO levels, suggesting that the formation of 
peroxynitrite (ONOO−) is one of the possible mechanisms 
of reducing NO bioavailability in JEG-3 cells, contributing 
to the reduction of NO-dependent migration capacity. 
Moreover, regarding the presence of NO-producing 
enzymes (eNOS and particularly iNOS) in human 
trophoblasts (Rossmanith et al., 1999; Hambartsoumian et 
al., 2001), we assume that long-term (72 h) NPY treatment 
might affect expression patterns of these enzymes. 
Stronger reduction in NO bioavailability, as well as more 
severe reduction of migration capacity recorded in long-
term NPY-treated cells in comparison to short-term NPY 
treatment, could be caused by prolonged production of 
reactive oxygen species (especially O2•–) and/or by changes 
in expression levels of NO-generating enzymes. In further 
research, we plan to investigate mRNA levels and protein 
quantification of iNOS in long-term NPY treatment of the 
same cell line. 
Although the majority of studies have reported invasion-
promoting effects of NPY on various cell types (Ruscica et 
al., 2007; Sheriff et al., 2010), there are a number of data 
that indicate its antimigratory and antiproliferative effects. 
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NPY administration to a variety of invasive cancers results 
in reduced invasive potential and/or decreased proliferation 
of cells of these tumors in a concentration-dependent 
manner. NPY administration to a number of prostate 
cancer cell lines inhibited the proliferation through an 
NPYR1-dependent mechanism, while NPY administration 
to cholangiocarcinoma cells in vitro reduced the invasion 
potential of these tumor cells in a concentration-dependent 
manner (Ogasawara et al., 1997; DeMorrow et al., 2011). 
One study indicated NPY as an inhibitor of migration of 
monocytes to the tissue (Nave et al., 2004). The results of 
our investigation also indicate an antimigratory role of NPY 
on human cytotrophoblast cells.
According to the results we conclude that NPY 
induces oxidative stress in human trophoblast cell line 
JEG-3 by stimulating increased production of oxygen 
reactive species such as O2•– and H2O2 both in short-
term (24 h) and long-term (72 h) treatments. The levels 
of GSH, as one of the main antioxidative components in 
trophoblasts, are increased probably due to its elevated de 
novo biosynthesis in response to NPY exposure, which 
implies considerable basal antioxidative capacity of human 
trophoblasts. Nevertheless, the increased levels of oxidized 
glutathione (GSSG) after long-term NPY exposure may 
suggest that NPY is a significant generator of oxidative 
stress, which can surpass the inherent trophoblast 
antioxidative capacity. The concentrations of nitric oxide 
are significantly decreased in trophoblasts exposed to 
NPY for both 24 h and 72 h of treatment compared to 
the control cells, as well as the migratory capacity of 
trophoblasts, with more severe reduction during long-
term (72 h) exposure. Based on these data, we proposed 
that 24 h and 72 h of NPY treatment reduced the migratory 
potential of human choriocarcinoma trophoblast cells by 
reducing the bioavailability of NO. The short-term and 
long-term treatments with a specific inhibitor of NOS 
enzymes (L-NAME) reduced the migration index of these 
cells. Accordingly, we assume that this motility reduction 
is caused by depleted bioavailability of NO, which affects 
NO-dependent migration pathways. NO is involved in 
the regulation of the function of cell adhesion molecules, 
presumably the integrins, important for cell motility. Since 
NO reduction is mediated by superoxide anion radical 
scavenging of free nitric oxide and possibly by altering 
the activities and expression patterns of NO-generating 
enzymes, we assume that NPY is responsible for depleted 
migration capacity of human trophoblasts by generating 
considerable oxidative stress in these cells. In future 
studies, we plan to examine the effects of NPY on the other 
antioxidant defense system components in trophoblasts, 
as well as on the expression patterns and activities of 
oxidative stress generating enzymes, such as NADPH 
oxidase. Furthermore, the impact of NPY on the activities 
and expressions of iNOS enzymes, and on the expression 
and distribution of both adhesion and invasion proteins, 
will be examined as well. These data should contribute 
to a better understanding of underlying mechanisms of 
placental disorders.
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